Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2005-04-29
2009-08-18
Shameem, Golam M (Department: 1626)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
C544S106000, C544S111000, C544S124000, C544S129000, C514S231200, C514S231500
Reexamination Certificate
active
07576083
ABSTRACT:
The present invention is directed to morpholinyl piperidine compounds that inhibit the glycine transporter GlyT1 and which are useful in the treatment of neurological and psychiatric disorders associated with glycinergic or glutamatergic neurotransmission dysfunction and diseases in which the glycine transporter GlyT1 is involved.
REFERENCES:
patent: 3097209 (1963-07-01), Janssen et al.
patent: 6376506 (2002-04-01), Broka et al.
patent: 2006/0276655 (2006-12-01), Blackaby et al.
patent: 2007/0105902 (2007-05-01), Lindsley et al.
patent: 2007/0254880 (2007-11-01), Blackaby et al.
patent: 2008/0021010 (2008-01-01), Lindsley et al.
patent: 2008/0090796 (2008-04-01), Blackaby et al.
patent: 2008/0108663 (2008-05-01), Lindsley et al.
Copending U.S. Appl. No. 11/922,074, filed Jun. 13, 2006, U.S. National Stage Entry of PCT/GB06/002156, published as WO 2006/134341.
Copending U.S. Appl. No. 11/991,727, filed Sep. 25, 2006, U.S. National Stage Entry of PCT/GB06/036989, published as WO 2007/041025.
Copending U.S. Appl. No. 12/084,027, filed Oct. 27, 2006, U.S. National Stage Entry of PCT/GB06/041699, published as WO 2007/053400.
Copending U.S. Appl. No. 12/085,340, filed Nov. 23, 2006, U.S. National Stage Entry of PCT/GB06/050411, published as WO 2007/060484.
Lindsley Craig W.
Wolkenberg Scott E.
Zhao Zhijian
Krovatin William
Merck & Co. , Inc.
Shameem Golam M
Yuro Raynard
LandOfFree
Morpholinyl piperidine glycine transporter inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Morpholinyl piperidine glycine transporter inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Morpholinyl piperidine glycine transporter inhibitors will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4126903